Primary Record
metolazone
- In stock
- 2,053 g
- Purity
- 98.1 %
- CAS
- 17560-51-9
Compound Identifiers & Properties
- CAS
- 17560-51-9
- PubChem CID
- 4170
- SMILES
- CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
- Canonical SMILES
- Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C
Names & Synonyms
- metolazone
- Zaroxolyn
- Diulo
- Mykrox
- Oldren
- Metenix
- Metalozone
- Microx
- Metolazona
- Metolazonum
- 17560-51-9
- metozalone
- Normelan
- Xuret
- Metalazone
- Metazoline
- Metolazonum [INN-Latin]
- Metolazona [INN-Spanish]
- Metolazone (Zaroxolyn)
- Zaroxolyn (TN)
- Metolazone CRS
- Metolazone-d7
- Metolazone, (+)-
- Metolazone, (-)-
- C16H16ClN3O3S
- Prestwick_333
- Metolazone[diuretic]
- Mykrox (TN)
- metolazone (product)
- Metolazone(Zaroxolyn)
- Metolazone (Standard)
- Metolazone(Zaroxolyn)/
- TZ7V40X7VX
- Spectrum_000456
- SR 720-22
- METOLAZONE [MI]
- RefChem:58440
- UNII-TZ7V40X7VX
- DTXSID6045167
- SR-720-22
- AC1L1HKJ
- METOLAZONE [INN]
- METOLAZONE [JAN]
- Prestwick0_000112
- Prestwick1_000112
- Prestwick2_000112
- Prestwick3_000112
- Spectrum2_001741
- Spectrum4_000229
- Spectrum5_001237
- METOLAZONE [HSDB]
- METOLAZONE [USAN]
- NM7V2Y3G0U
- AQCHWTWZEMGIFD-UHFFFAOYSA-N
- Metolazone (JAN/USP/INN)
- METOLAZONE [VANDF]
- CHEMBL878
- D01WLC
- UNII-NM7V2Y3G0U
- HSDB 3367
- METOLAZONE [MART.]
- Metolazone[hypotensive drug]
- (non-labelled)Metolazone-d7
- METOLAZONE [USP-RS]
- METOLAZONE [WHO-DD]
- Metolazone [USAN:BAN:INN:JAN]
- SCHEMBL40558
- BSPBio_000124
- BSPBio_002422
- DTXCID4025167
- KBioGR_000897
- KBioSS_000936
- CHEBI:64354
- MLS002153316
- MLS002154200
- orb134400
- DivK1c_000275
- NSC-759581
- SPECTRUM2300325
- 7-Chloro-2-methyl-4-oxo-3-(o-tolyl)-1,2,3,4-tetrahydroquinazoline-6-sulfonamide
- EINECS 241-539-3
- SPBio_001842
- SPBio_002063
- MFCD00069304
- BPBio1_000138
- GTPL4838
- orb2815831
- METOLAZONE [EP IMPURITY]
- METOLAZONE [ORANGE BOOK]
- Mykrox;Zaroxolyn;Diulo;Zaroxolyn
- SCHEMBL29382896
- UNII-NN9U607695
- BDBM25899
- CTK8B4741
- ERK5-2O16
- HMS500N17
- HY-B0209R
- KBio1_000275
- KBio2_000936
- KBio2_003504
- KBio2_006072
- KS-00000ZJQ
- SR72022
- 6-Quinazolinesulfonamide, 7-chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-
- 7-Chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide
- BRN 0965506
- C03BA08
- CID4170
- METOLAZONE [EP MONOGRAPH]
- NINDS_000275
- BCPP000166
- GLXC-05373
- HMS1568G06
- HMS1922L16
- HMS2093P14
- HMS2095G06
- HMS2230J15
- HMS3261J22
- HMS3373C11
- HMS3655M09
- HMS3712G06
- HMS3744I19
- HMS5079C20
- METOLAZONE [USP MONOGRAPH]
- Pharmakon1600-02300325
- Metolazone [USAN:INN:BAN:JAN]
- NN9U607695
- BCP21574
- CID:4170
- EBD54305
- HY-B0209
- Metolazone [USAN:USP:INN:BAN:JAN]
- MSK10506
- C16-H16-Cl-N3-O3-S
- Tox21_110186
- Tox21_113526
- Tox21_500610
- 2-BROMO-5-NITRONICOTINICACID
- ABP000634
- ANW-46001
- CCG-39450
- EBC-11132
- NCGC00093985-07
- NSC759581
- s1610
- Metolazone for system suitability CRS
- Mykrox, Zaroxolyn, Diulo, Metolazone
- AKOS015897109
- Metolazone, >=98% (HPLC), solid
- Tox21_110186_1
- 7-Chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-o-tolyl-6-quinazolinesulfonamide
- BCP9000920
- CS-2150
- DB00524
- FM25978
- J3.450I
- KS-5139
- LP00610
- NSC 759581
- SDCCGSBI-0051460.P003
- SR 720 22
- IDI1_000275
- 2-Methyl-3-o-tolyl-6-sulfamyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone
- NCGC00015630-02
- NCGC00093985-01
- NCGC00093985-02
- NCGC00093985-03
- NCGC00093985-04
- NCGC00093985-05
- NCGC00093985-06
- NCGC00093985-08
- NCGC00093985-10
- NCGC00093985-11
- NCGC00093985-20
- NCGC00261295-01
- 4CA-0814
- AN-11710
- AS-13016
- H024
- SMR001230730
- 7-chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2,3,4-tetrahydroquinazoline-6-sulfonamide
- SBI-0051460.P002
- SID:134222276
- 2-Methyl-3-(o-tolyl)-6-sulfamyl-7-chlor
- 7-chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide
- AB0012835
- AB2000160
- CAS-17560-51-9
- DB-044227
- LS-140226
- TC-134746
- AB00052055
- NS00004329
- ST24029920
- SW196612-3
- 5-25-09-00212 (Beilstein Handbook Reference)
- D00431
- AB00052055-08
- AB00052055_09
- AB00052055_10
- 560M519
- A812099
- D008788
- EN300-23818025
- SR-05000001765
- 6-Quinazolinesulfonamide, 1,2,3,4-tetrahydro-7-chloro-2-methyl-4-oxo-3-o-tolyl-
- 6-Quinazolinesulfonamide, 7-chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-o-tolyl-
- Q1169561
- SR-05000001765-1
- SR-05000001765-4
- SR-05000001765-7
- BRD-A61793559-001-05-7
- BRD-A61793559-001-08-1
- BRD-A61793559-001-14-9
- BRD-A61793559-001-15-6
- BRD-A61793559-001-16-4
- Metolazone, European Pharmacopoeia (EP) Reference Standard
- 56436-32-9
- 7-chloro-2-methyl-3-(o-tolyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide
- Metolazone, United States Pharmacopeia (USP) Reference Standard
- 6-Quinazolinesulfonamide, 7-chloro-1,2,3,4-tetrahydro- 2-methyl-3-(2-methylphenyl)-4-oxo-
- 56436-31-8
- 6-Quinazolinesulfonamide, 7-chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-, (+)-
- 6-Quinazolinesulfonamide, 7-chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-, (-)-
- 7-Chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2,3,4-tetrahydro-6-quinazolinesulfonamide #
- 7-Chloro-2-methyl-4-oxo-3-(o-tolyl)-1,2,3,4-tetrahydroquizoline-6-sulfomide
- 7-chloro-2-methyl-4-oxo-3-o-tolyl-1,2,3,4-tetrahydroquinazoline-6-sulfonamide
- Metolazone for system suitability, European Pharmacopoeia (EP) Reference Standard
- 241-539-3
- 7-Chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide-d7; 2-Methyl-3-(o-tolyl)-6-sulfamyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone-d7; Diulo-d7; Metenix-d7; Metozalone-d7; Mykrox-d7; Normelan-d7; Oldren-d7; SR 720-22-d7; Xuret-d7; Zaroxolyn-d7;
- Metolazone; (2RS)-7-Chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2,3,4-tetrahydroquinazoline-6-sulfonamide